August 5, 2015 – Aimmune Therapeutics announced today the pricing of its initial public offering at $16.00 per share. Trading is to begin tomorrow on NASDAQ under the symbol AIMT. Company press release. FLG partner: Victor Colunga.
SEATTLE-November 16, 2022 -(BUSINESS WIRE)–Curevo Vaccine (Curevo), a privately held clinical-stage biotechnology company dedicated to reducing the burden of infectious disease by developing safe and highly-effective vaccines, today announced the closing of a $26 million Series A1 financing round. This brings total funding raised in 2022 to $86M for the…Read More
You’ve been a tremendous asset to Coinbase during a very chaotic and complex time. Thank you deeply for everything you’ve done by stepping in to provide guidance and leadership to the team over the last year. Coinbase wouldn’t be where it’s at today without you and I appreciate all you’ve done for this company and our leadership team.
Adam White, Former VP Institutional, Coinbase Read More